{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:40:06Z","timestamp":1761154806553},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T00:00:00Z","timestamp":1122336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00403-005-0585-5","type":"journal-article","created":{"date-parts":[[2005,7,25]],"date-time":"2005-07-25T08:00:04Z","timestamp":1122278404000},"page":"94-98","source":"Crossref","is-referenced-by-count":16,"title":["An insertion\/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population"],"prefix":"10.1007","volume":"297","author":[{"given":"Samia","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos G.","family":"Gavalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Gawkrodger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip F.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P.","family":"Weetman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Helen","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,7,26]]},"reference":[{"key":"585_CR1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/11.6.661","volume":"11","author":"A Alkhateeb","year":"2001","unstructured":"Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, Fox A, Miller C, Dills DG, Ridgway EC, Bennett DC, Fain PR, Spritz RA (2001) Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p313-p322. Hum Mol Genet 11:661\u2013667","journal-title":"Hum Mol Genet"},{"key":"585_CR2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2249.1996.d01-727.x","volume":"105","author":"E Baharav","year":"1996","unstructured":"Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrund B, Yecheskel G (1996) Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105:84\u201388","journal-title":"Clin Exp Immunol"},{"key":"585_CR3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0923-1811(92)90017-6","volume":"4","author":"PS Bhatia","year":"1992","unstructured":"Bhatia PS, Mohan L, Pandey ON, Singh KK, Arora SK, Mukhija RD (1992) Genetic nature of vitiligo. J Dermatol Sci 4:180\u2013184","journal-title":"J Dermatol Sci"},{"key":"585_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0749.2004.00196.x","volume":"18","author":"A Blomhoff","year":"2005","unstructured":"Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen A, Lie BA, Undlien DE (2005) CTLA4 polymorphisms are associated with vitiligo in patients with concomitant autoimmune diseases. Pigment Cell Res 18:55\u201358","journal-title":"Pigment Cell Res"},{"key":"585_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0749.1995.tb00774.x","volume":"8","author":"J Cui","year":"1995","unstructured":"Cui J, Arita Y, Bystryn J-C (1995) Characterisation of vitiligo antigens. Pigment Cell Res 8:53\u201359","journal-title":"Pigment Cell Res"},{"key":"585_CR6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF01747982","volume":"63","author":"H Czernobilsky","year":"1985","unstructured":"Czernobilsky H, Fiehn W, Ziegler R (1985) Comparison of serum angiotensin-converting enzyme in Graves\u2019 disease, toxic nodular goiter, and other thyroid conditions. Klin Wochenschr 63:518\u2013522","journal-title":"Klin Wochenschr"},{"key":"585_CR7","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1086\/375451","volume":"72","author":"PR Fain","year":"2003","unstructured":"Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, Bennett DC, Spritz RA (2003) A genomewide screen for generalised vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 72:1560\u20131564","journal-title":"Am J Hum Genet"},{"key":"585_CR8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","volume":"105","author":"A Gilhar","year":"1995","unstructured":"Gilhar A, Zelickson B, Ulman Y, Etzioni A (1995) In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo. J Invest Dermatol 105:683\u2013686","journal-title":"J Invest Dermatol"},{"key":"585_CR9","doi-asserted-by":"crossref","DOI":"10.1002\/9780470760116","volume-title":"Vitiligo","author":"S-K Hann","year":"2000","unstructured":"Hann S-K, Nordlund J (2000) Vitiligo. Blackwell Science, Oxford, UK"},{"key":"585_CR10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0020-711X(91)90032-I","volume":"23","author":"NM Hooper","year":"1991","unstructured":"Hooper NM (1991) Angiotensin converting enzyme: implications from molecular biology for its physiological functions. Int J Biochem 23:641\u2013647","journal-title":"Int J Biochem"},{"key":"585_CR11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1600-0749.2003.00105.x","volume":"17","author":"SY Jin","year":"2004","unstructured":"Jin SY, Park HH, Li GZ, Lee HJ, Hong MS, Hong SJ, Park HK, Chung JH, Lee MH (2004) Association of angiotensin converting enzyme gene I\/D polymorphism of vitiligo in Korean population. Pigment Cell Res 17:84\u201386","journal-title":"Pigment Cell Res"},{"key":"585_CR12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","volume":"109","author":"EH Kemp","year":"1997","unstructured":"Kemp EH, Gawkrodger DJ, MacNeil S, Watson PF, Weetman AP (1997) Detection of tyrosinase autoantibodies in vitiligo patients using 35 S-labelled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol 109:69\u201373","journal-title":"J Invest Dermatol"},{"key":"585_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2133.1999.02610.x","volume":"140","author":"EH Kemp","year":"1999","unstructured":"Kemp EH, Ajjan RA, Waterman EA, Gawkrodger DJ, Cork MC, Watson PF, Weetman AP (1999) Analysis of a cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism in patients with vitiligo. Br J Dermatol 140:73\u201378","journal-title":"Br J Dermatol"},{"key":"585_CR14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.175.6.1417","volume":"175","author":"S Kozlowski","year":"1992","unstructured":"Kozlowski S, Corr M, Takeshita T, Boyd LF, Pendleton CD, Germain RN, Berzofsky JA, Margulies DH (1992) Serum angiotensin converting enzyme activity processes a human immunodeficiency virus 1 g160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med 175:1417\u20131422","journal-title":"J Exp Med"},{"key":"585_CR15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","volume":"116","author":"KS Lang","year":"2001","unstructured":"Lang KS, Caroli CC, Muhm A, Wernet D, Moris A, Schittek B, Knauss-Scherwitz E, Stevanovic S, Rammensee H-G, Garbe C (2001) HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1. J Invest Dermatol 116:891\u2013897","journal-title":"J Invest Dermatol"},{"key":"585_CR16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0009-9120(01)00281-8","volume":"34","author":"M-H Lin","year":"2001","unstructured":"Lin M-H, Tseng C-H, Tseng C-C, Huang C-H, Chong C-K, Tseng C-P (2001) Real-time PCR for rapid genotyping of angiotensin converting enzyme insertion\/deletion polymorphism. Clin Biochem 34:661\u2013666","journal-title":"Clin Biochem"},{"key":"585_CR17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archderm.1993.01680290066010","volume":"129","author":"PP Majumder","year":"1993","unstructured":"Majumder PP, Nordlund JJ, Nath SK (1993) Pattern of familial aggregation of vitiligo. Arch Dermatol 129:994\u2013998","journal-title":"Arch Dermatol"},{"key":"585_CR18","first-page":"231","volume":"14","author":"WT McCormack","year":"2001","unstructured":"McCormack WT, Bradley CA, Kristensen DL, She JX (2001) Genetics of vitiligo susceptibility: association studies of immune response genes. Pigment Cell Res 14:231","journal-title":"Pigment Cell Res"},{"key":"585_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","volume":"17","author":"K Nagamine","year":"1997","unstructured":"Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis, SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECED gene. Nat Genet 17:393\u2013398","journal-title":"Nat Genet"},{"key":"585_CR20","first-page":"981","volume":"55","author":"SK Nath","year":"1994","unstructured":"Nath SK, Majumder PP, Nordlund JJ (1994) Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 55:981\u2013990","journal-title":"Am J Hum Genet"},{"key":"585_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","volume":"90","author":"DA Norris","year":"1998","unstructured":"Norris DA, Kissinger RM, Naughton GK, Bystryn J-C (1998) Evidence for immunologic mechanisms in human vitiligo: patients\u2019 sera induce damage to human melanocytes in\u00a0vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol 90:783\u2013789","journal-title":"J Invest Dermatol"},{"key":"585_CR22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-71-5-935","volume":"71","author":"Y Ochi","year":"1969","unstructured":"Ochi Y, DeGroot LJ (1969) Vitiligo in Graves\u2019 disease. Ann Intern Med 71:935\u2013940","journal-title":"Ann Intern Med"},{"key":"585_CR23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","volume":"188","author":"GS Ogg","year":"1998","unstructured":"Ogg GS, Dunbar PR, Romero P, Chen J-L, Cerundolo V (1998) High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 188:1203\u20131208","journal-title":"J Exp Med"},{"key":"585_CR24","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","volume":"111","author":"T Okamoto","year":"1998","unstructured":"Okamoto T, Irie RF, Fujii S, Huang SK, Nizze AJ, Morton DL, Hoon DS (1998) Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol 111:1034\u20131039","journal-title":"J Invest Dermatol"},{"key":"585_CR25","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","volume":"96","author":"WW Overwijk","year":"1999","unstructured":"Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, Carroll MW, Moss B, Rosenberg SA, Restifo NP (1999) Vaccination with a recombinant vaccinia virus encoding a \u201cself\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci USA 96:2982\u20132987","journal-title":"Proc Natl Acad Sci USA"},{"key":"585_CR26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","volume":"117","author":"B Palermo","year":"2001","unstructured":"Palermo B, Campanelli R, Garbelli S, Mantovani S, Lantelme E, Brazzelli V, Ardigo M, Borroni G, Martinetti M, Badulli C, Necker A, Giachino C (2001) Specific cytotoxic T lymphocyte responses against MelanA\/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 117:326\u2013332","journal-title":"J Invest Dermatol"},{"key":"585_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2796.2000.00575.x","volume":"247","author":"K Papadopoulos","year":"2000","unstructured":"Papadopoulos K, Melander O, Orho-Melander M, Groop LC, Carlsson M, Hallengren B (2000) Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune disease. J Int Med 247:71\u201377","journal-title":"J Int Med"},{"key":"585_CR28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","volume":"86","author":"B Rigat","year":"1990","unstructured":"Rigat B, Hubert C, Alhenc-Getes F, Cambien F, Corvol P, Soubrier F (1990) An insertion\/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343\u20131346","journal-title":"J Clin Invest"},{"key":"585_CR29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/nar\/20.6.1433-a","volume":"20","author":"B Rigat","year":"1992","unstructured":"Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion\/deletion polymorphism of the human angiotensin converting enzyme gene. Nucleic Acids Res 20:1433","journal-title":"Nucleic Acids Res"},{"key":"585_CR30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","volume":"19","author":"SA Rosenberg","year":"1996","unstructured":"Rosenberg SA, White DE (1996) Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy. J Immunother Emphasis Tumor Immunol 19:81\u201384","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"585_CR31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0625.1998.tb00307.x","volume":"7","author":"T Scholzen","year":"1998","unstructured":"Scholzen T, Armstorng CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81\u201396","journal-title":"Exp Dermatol"},{"key":"585_CR32","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.4049\/jimmunol.170.7.3866","volume":"170","author":"TE Scholzen","year":"2003","unstructured":"Scholzen TE, Stander S, Riemann H, Brzoska T, Luger TA (2003) Modulation of cutaneous inflammation by angiotensin converting enyme. J Immunol 170:3866\u20133873","journal-title":"J Immunol"},{"key":"585_CR33","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","volume":"344","author":"YH Song","year":"1994","unstructured":"Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N (1994) The role of tyrosinase in autoimmune vitiligo. Lancet 344:1049\u20131052","journal-title":"Lancet"},{"key":"585_CR34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","volume":"74","author":"RA Spritz","year":"2004","unstructured":"Spritz RA, Gowan K, Bennett DC, Fain PR (2004) Novel vitiligo susceptibility loci on chromosomes 7 (ASI2) and 8 (ASI3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 74:188\u2013191","journal-title":"Am J Hum Genet"},{"key":"585_CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0749.2004.00141.x","volume":"17","author":"HB Tastan","year":"2004","unstructured":"Tastan HB, Akak A, Orkunoglu FE, Arca E, Inal A (2004) Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 17:181\u2013184","journal-title":"Pigment Cell Res"},{"key":"585_CR36","first-page":"499","volume":"72","author":"Z Vuk-Pavlovic","year":"1988","unstructured":"Vuk-Pavlovic Z, Rohrbach MS (1988) An in\u00a0vitro model for the induction of angiotensin converting enzyme in sarcoidosis: possible parallels to the immune response Clin Exp Immunol 72:499\u2013504","journal-title":"An in\u00a0vitro model for the induction of angiotensin converting enzyme in sarcoidosis: possible parallels to the immune response Clin Exp Immunol"},{"key":"585_CR37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","volume":"19","author":"B Woolf","year":"1955","unstructured":"Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251\u2013253","journal-title":"Ann Hum Genet"},{"key":"585_CR38","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","volume":"192","author":"C Yee","year":"2000","unstructured":"Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddell SR, Greenberg PD (2000) Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo. J Exp Med 192:1637\u20131644","journal-title":"J Exp Med"},{"key":"585_CR39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.2001.04288.x","volume":"145","author":"M Zamani","year":"2001","unstructured":"Zamani M, Spaepen M, Sghar SS, Huang C, Westerhof W, Nieuweboer-Krobotova L, Cassiman JJ (2001) Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 145:90\u201394","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-005-0585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-005-0585-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-005-0585-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:37:34Z","timestamp":1559065054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-005-0585-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,26]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1007\/s00403-005-0585-5","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,26]]}}}